Table 1 Data characteristics of research samples and results of univariate analysis (n = 346)

Age (years)

 < 45

88 (25.43)

99.65 ± 19.99

45–54

141 (40.75)

104.41 ± 19.00

 ≥ 55

117 (32.82)

103.46 ± 18.17

BMI

Low weight

6 (1.73)

116.67 ± 22.23

Normal weight

157 (45.38)

101.22 ± 19.34

Overweight

154 (44.51)

104.28 ± 18.67

Obesity

29 (8.38)

101.55 ± 17.77

Marital status

Married

294 (84.97)

103.26 ± 19.23

Unmarried

9 (2.60)

93.11 ± 20.31

Divorced

27 (7.80)

101.67 ± 18.43

widowed

16 (4.62)

103.44 ± 15.27

Education level

Junior high school and below

96 (27.75)

100.73 ± 20.16

High school/technical secondary school

94 (27.17)

100.59 ± 20.49

Junior college

71 (20.52)

108.28 ± 16.42

Bachelor's degree

78 (22.54)

103.17 ± 17.76

Master degree or above

7 (2.02)

105.14 ± 13.21

Professional

Retired

142 (41.04)

104.19 ± 17.53

Did not work

92 (26.59)

100.25 ± 20.88

Temporary worked

13 (3.76)

96.46 ± 19.71

Work as usual

99 (28.61)

104.28 ± 19.06

Exercise

Regular exercise

150 (43.35)

107.47 ± 17.76

Irregular exercise

174 (50.29)

100.76 ± 18.76

No exercise

22 (6.36)

88.32 ± 20.00

Medical payment method

Self-pay

16 (4.62)

94.00 ± 17.09

Urban basic medical insurance

268 (77.46)

104.28 ± 18.87

Commercial medical insurance

5 (1.45)

83.80 ± 14.02

Cooperative medical insurance

50 (14.45)

99.90 ± 20.09

Others

7 (2.02)

104.43 ± 11.79

Endocrine drug

Tamoxifen

128 (36.99)

103.97 ± 17.35

furlong (Letrozole)

76 (21.97)

100.87 ± 19.65

Exemestane (Arnoxine)

45 (13.01)

102.91 ± 18.10

Torremifene (fareston)

45 (13.01)

105.29 ± 18.06

Others

52 (15.02)

101.02 ± 23.45

Discomfort symptoms

Nausea

Yes

14 (4.05)

101.29 ± 20.55

No

332 (95.95)

102.95 ± 18.99

Headache

Yes

28 (8.09)

96.43 ± 19.34

No

318 (91.91)

103.45 ± 18.92

Hot flash

Yes

164 (47.40)

101.70 ± 19.10

No

182 (52.60)

103.94 ± 18.95

Memory loss

Yes

162 (46.82)

99.88 ± 20.05

No

184 (53.18)

105.52 ± 17.72

Arthralgia

Yes

138 (39.88)

98.96 ± 19.58

No

208 (60.12)

105.48 ± 8.24

Ankylosis

Yes

124 (35.84)

100.31 ± 20.26

No

222 (64.16)

104.32 ± 18.19

Perturbation

Yes

46 (13.29)

97.57 ± 18.02

No

300 (86.71)

103.69 ± 19.07

Hyperplasiaendometrii

Yes

40 (11.56)

99.55 ± 16.16

No

306 (88.44)

103.31 ± 19.35

Uterinefibroid

Yes

24 (6.94)

106.42 ± 17.68

No

322 (93.06)

102.61 ± 19.12

Menoxenia

Yes

45 (13.01)

102.67 ± 19.06

No

301 (86.99)

102.91 ± 19.05

Gain weight

Yes

112 (32.37)

101.38 ± 19.08

No

234 (67.63)

103.60 ± 19.00

Types of discomfort symptoms

1 species

109 (31.50)

107.34 ± 17.50

2 species

87 (25.14)

103.64 ± 18.43

3 species

62 (17.92)

102.34 ± 19.95

4 species

45 (13.01)

101.00 ± 18.23

5 species

20 (5.78)

88.60 ± 24.71

 ≥ 6 species

23 (6.65)

96.39 ± 14.60

The years of diagnosis

 ≤ 5

298 (86.13)

101.87 ± 19.60

 > 5

48 (13.97)

109.15 ± 13.52

The duration of medication

 < 3

175 (50.58)

100.57 ± 19.80

3–6

145 (41.91)

104.17 ± 18.35

 > 6

26 (7.51)

111.27 ± 14.42

Psychosocial adaptation

 ≤ 38

137 (39.60)

87.64 ± 16.73

 > 38

209 (60.40)

112.87 ± 12.81

Medication adherence

Low adherence

131 (37.86)

99.15 ± 19.24

Moderate adherence

135 (39.02)

103.33 ± 19.70

High adherence

80 (23.12)

108.23 ± 16.17